Organigram is a licensed producer of medical marijuana and regulated by Health Canada.

TSX Venture (OGI)

OTCQB Venture Marketplace (OGRMF)

January 31st , 2017. The information contained in this presentation is provided by Organigram (“OGI”) for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of OGI or other financial products. The information contained herein is not investment or financial product advice and is not intended to be used as the basis for making an investment decision.

The views, opinions and advice provided in this presentation reflect those of the individual presenters, and are provided for information purposes only. The presentation has been prepared without taking into account the investment objectives, financial situation or particular needs of any particular person. No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation. To the maximum extent permitted by law, none of OGI nor its directors, officers, employees or agents, nor any other person accepts any liability, including, without limitation, any liability arising out of fault or negligence, for any loss arising from the use of the information contained in this presentation.

Except for statements of historical fact, this presentation contains certain “forward-looking information” within the meaning ofapplicable securities laws. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, andare subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements, including, among others, OGI’s future growth and development, the ability to create value through mineral property transactions, the proposed plans of any of OGI’s equity holdings, as well as those risk factors identified in OGI’s Filing Statement and other disclosure documents available at www.sedar.com under OGI’s name. OGI undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements.

This presentation does not constitute an offer of shares for sale in the United States or to any person that is, or is acting for the account or benefit of, any U.S. person (as defined in Regulation S under the United States Securities Act of 1933, as amended (the “Securities Act”) (“U.S. Person”), or in any other jurisdiction in which such an offer would be illegal. OGI’s shares have not been and will not be registered under the Securities Act.

2www.organigram.ca

Disclaimers and Cautionary Statements

3www.organigram.ca

Medical Marijuana In Canada

• On April 1, 2014, Marihuana for Medical Purposes Regulations (“MMPR”) came into effect

• Program was replaced by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) in August, 2016

• Patients obtain a prescription from a physician, stating quantity of grams permitted per day

• Licensed producers (LPs) register patients directly and ship medicine direct to the patient’s home

• Enrolment has grown over 10% per month during 2015-2016; and now stands at over 130,000 patients

Medical Market Growth Projection

Recent political developments have opened the door to recreational legalization

4www.organigram.ca

Political Developments – Recreational Marijuana

• Oct-2015: The Trudeau Liberals win a majority government

• Canadian parliamentary system permits majority

government to pass legislation unopposed until the next

federal election, October 20191

• Dec-2015: Throne speech reaffirms Trudeau plan to legalize pot2

• April-2016: Health Minister announces intent to legalize

marijuana in 2017 at the United Nations General Assembly

• June-2016: Federal task force appointed to review and report on

marijuana legalization

• Nov-2016: Federal task force provides a final report on Cannabis

Legalization and Regulation3:

“We will legalize, regulate, and restrict access to marijuana.”4

Justin Trudeau, Prime Minister of Canada

1 Source: Liberal government. www.liberal.ca/realchange/marijuana.2 Source: Global News, December 4, 2015 – “Throne speech reaffirms Trudeau plan to legalize pot.”3 Source: November 30th, 2016 – A Framework for the Legalization and Regulation OF Cannabis in Canada

“ESTABLISHING A SAFE AND RESPONSIBLE SUPPLY CHAIN, ENFORCING PUBLIC SAFETY & PROTECTION, MEDICAL ACCESS AND IMPLEMENTATION”

5

Overview of Organigram

Premium Organic Product

Favorable Cost Structure

Scalable Production

Facilities

Differentiated Products and

Brands

Management -Capitalized

Balance Sheet

6

Overview of Organigram

Strategic Location• Only producer with a license to sell, east of Québec

- Bilingual branding and services

Favorable Cost Structure• Optimized, low cost producer

- 5.11 cents/kWh versus ~ 18 cents/kWh in Ontario- Low operating costs and wages

Scalable Production Facilities• Two buildings on 14 acres of land • Current production capacity increase of 4,200 kg/yr• Ongoing fully financed expansion to over 26,000 kg/yr

(est Dec/17)

• Including a 15,000 sq ft extracts processing facility

Differentiated Products and Brands• The Green Solution (TGS) & NectarBee• Trailer Park Boys

Prudent Management Team• Experienced and proven senior management team• Aligned with investors (~15% ownership)

Inside Production Facility: Moncton, New Brunswick

Note: Production estimates are based on a targeted yield of 1.8 lbs (817 grams) per light and 5.5 turns per year.

Note: For detailed expansion schematic, refer to appendix E.

7www.organigram.ca

Facility Highlights: Ongoing Expansion

Expansion SpecificsExpansion Overhead View

Completion

Phase Status Date Area

Phase 1 Completed 31,160

Phase 2 Under Construction Feb. '17 6,706

Phase 3 Under Construction Oct. '17 81,673

Phase 3A Under Construction Oct. '17 13,746

Phase 4 New Building Feb. '18 35,715

Leased Space 58,503

Completed Total Area (Sq. Ft.) 227,503

• On August 31st – Organigram strategically acquired the property adjacent to the existing licenced facility• 136,000 sq ft industrial building situated on 10 acres• Includes ongoing annual rental income of $770,000 – blue chip tenant

• When completed, the fully funded expansion will total 227,503 square feet• Expected pro-forma production capacity of over 26,000 kg/yr• Planned In-house extracts processing facility spanning ~15,000 square feet

8

Brand Development - The Green Solution TM / nectarbee TM

• Entered into an exclusive Canadian product development and distribution agreement with TGS International

• Commercial scale extracts and processing capability• Portfolio of over 225 unique cannabis products

• Proven market leader based in Denver, Colorado• Over $100mln in cumulative product sales• 13 established retail locations

• Award winning cannabis product lines

• Recognized premium brands and product offering

• Pending retail expansions into:• Illinois, Florida, Maryland and Oregon

TGS Strategically Positions Organigram for a Recreational Market

Brands and Product Offering

9

Brand Development - Trailer Park BoysTM

• On November 23rd Organigram announced a licencing agreement with the Trailer Park Boys (TPB Productions Ltd.)

• Organigram will be the exclusive Canadian: • Cannabis Producer• Business Partner and Brand Developer

• Organigram will work to develop branding, packaging, and a competitive product portfolio targeted towards recreational marijuana consumers and distributed exclusively by Organigram

• Consideration to include a combination of cash royalties and other non-monetary considerations

Branding and Value Added Products are Essential in a Recreational Market

Trailer Park Boys

Avg. Selling Price Per

Gram of Dried Cannabis to

Medical Patients

Cost of Goods Sold

Low costProducer(excludes f.v.

adjustment to bio-assets and inventory)

Sales Increased

Year over year

(Q1 2017 vs Q1 2016)

Cash Flow Q1 2017

10www.organigram.ca

Key Performance Indicators

$1.69Q1, 2017

$8.75Q1, 2017

117% Sales Growth

$510,015

11

Contact Information and Share Capitalization

Organigram Holdings Inc.35A English Dr.

Moncton, NB, E1E 3X3

info@organigram.caToll Free: 1-855-961-9420

Local: 1-506-384-1571Fax: 1-855-267-1386

Giselle DoironDirector of Investor & Media Relations

investorrelations@organigram.caDirect Line: 506-801-8986

Cell: 506-380-0132Toll Free: 1-855-961-9420

Issued and Outstanding 100,911,922

Warrants ($1.27 weighted avg. strike) 6,163,391

Options ($1.14 weighted avg. strike) 4,816,182

Fully Diluted 111,891,495

Management / Insider Ownership 15%

Institutional Ownership 25%

TSX Venture OGI

OTCQB Venture Marketplace OGRMF

Share and Ownership Structure

Note: Figures as of December 31st, 2016

Denis Arsenault – Chief Executive Officer and DirectorMr. Arsenault has spent the past 30 years as a successful entrepreneur, building, running and selling several profitable businesses. As the Chief Executive Officer of the Company, Mr. Arsenault has focused on growing the Company into a sustainable and successful employer in Moncton. His extensive knowledge and experience in building successful enterprises has helped to establish a strong management team and a modern production facility. Mr. Arsenault holds a Bachelor of Administration degree from the Université de Moncton.

Larry Rogers – Chief Operating Officer and DirectorMr. Rogers was the Chief Executive Officer and co-founder of CLS Lexi-tech Ltd., an Irving Group owned company, Canada’s largest private language service provider. He began his career in the information technology field, before going on to play a key role in the creation and growth of Lexi-tech International Inc., first as Vice-President of Operations then as President from 2001. Mr. Rogers holds a Bachelor of Science degree, with a major in computer science degree from the University of New Brunswick.

Peter R. Hanson – Interim Chief Financial OfficerPeter joined Organigram Inc. in August 2014 and before his most recent appointment to interim CFO he held the position of Director of Finance &Administration. Prior to his joining Organigram Inc., Peter had 20 years of experience in the field of finance and administration primarily in themanufacturing and services sector. Peter possesses a demonstrated track record in finance, human resource management and strategic planning.Peter holds a Bachelor of Commerce degree from Mount Allison University. Peter also holds a Chartered Professional Accountant designation and aChartered Professional in Human Resources designation, in the Province of New Brunswick.

Raymond Gracewood – Chief Commercial OfficerAs the previous Senior Director of Sales and Marketing for Moosehead Breweries Ltd., Mr. Gracewood is a leading brand and marketing professional in Atlantic Canada. With more than 15 years of experience in the marketing space, he is a strong speaker on brand, packaging and positioning, both locally and throughout North America. He has extensive experience in building and developing brands, positioning and segmentation. Mr. Gracewood holds a Bachelor of Business Administration degree, from the University of New Brunswick.

12www.organigram.ca

Appendix A: Management

Monique Imbeault – Chairman of the BoardMrs. Imbeault is currently Chief Executive Officer of General Financial Corporation Ltd. (“GFC”), a holding company with a diverse portfolio of investments. Prior to joining GFC, she was Counsel with McInnes Cooper. She received her LL.B from the Université de Moncton and a BSC, (Chemistry) and an Engineering Certificate from Mount Allison University. Mrs. Imbeault is currently on the Board of XL-ID Solutions Inc. and of Resilia Inc., two privately held companies; she is also Chair of the Board of the New Brunswick Health Research Foundation and the Atlantic Institute of Neurosciences and a member of the Board of Directors of the CHU Dumont Foundation. She has sat on boards of publicly traded companies and was previously Chair of the Board of Imvescor Restaurant Group Inc. Mrs. Imbeault has completed the Director Education Program at the RotmanSchool of Management and has received her ICD.D designation, granted by the Institute of Corporate Directors.

Michel Bourque – DirectorMr. Bourque brings more than 25 years of sales and marketing leadership experience in the pharmaceutical industry, having worked in the branded Rx, generic Rx and branded/private label OTC sectors. Over this time, he has successfully led teams in the specialty medicine, hospital and retail key account areas driving profitable growth through strategic planning and the implementation of innovative value-added programs. Mr. Bourque holds a Bachelor of Business Administration degree from l’Université de Moncton.

Peter Amirault – DirectorMr. Amirault is currently the President of BML Group Limited in Toronto, a holding company with interests in real estate development and private investments. Prior to joining BML Group, Peter held varying executive roles including: President of Swiss Chalet North America for the Cara Group of Companies, CEO of Creemore Springs Brewery Ltd, Senior Vice President of Molson Coors Canada, Managing Director of Sleeman Brewing Ltd, along with senior roles at Nestle Canada and The Premium Beer Company of Toronto. Peter holds a BBA from Acadia University and an MBA from The Schulich School of Business. Peter brings a wealth of knowledge with his previous board experience and roles at senior management levels.

Dr. Kenneth Mitton – DirectorDr. Mitton is a highly respected physician, practicing in Moncton, New Brunswick. Dr. Mitton has practiced medicine for over 30 years as a family doctor. He also advises a number of large corporations in New Brunswick, with respect to occupational health matters. Dr. Mitton has previously served as the Chief of Staff of the South-East Regional Health Authority (now the Horizon Health Network) and is currently the medical director of the Moncton Hospital. Dr. Mitton holds a Bachelor of Science and a Doctor of Medicine Degree from Dalhousie University.

Denis Arsenault – Chief Executive Officer and DirectorLarry Rogers – Chief Operating Officer and Director

13www.organigram.ca

Appendix B: Board of Directors